OTCMKTS:PBSV - Pharma Bio Serv Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $0.61 0.00 (0.00 %) (As of 07/23/2018 06:00 AM ET)Previous Close$0.61Today's Range$0.61 - $0.6152-Week Range$0.3250 - $0.70Volume3,100 shsAverage Volume5,317 shsMarket Capitalization$14.11 millionP/E Ratio-10.17Dividend YieldN/ABeta0.45 Company ProfileEarnings HistoryInsider TradesHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm with a laboratory testing facility in Puerto Rico, the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also offers microbiological and chemical testing services through its lab; and technical trainings/seminars. The company markets its services through industry trade shows, professional conventions, industry publications, and seminars. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. Receive PBSV News and Ratings via Email Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Management consulting services Sub-IndustryN/A SectorBusiness Services SymbolOTCMKTS:PBSV CUSIPN/A Webwww.pharmabioserv.com Phone787-278-2709 Debt Debt-to-Equity RatioN/A Current Ratio10.23 Quick Ratio10.23 Price-To-Earnings Trailing P/E Ratio-10.17 Forward P/E Ratio-5.08 P/E GrowthN/A Sales & Book Value Annual Sales$15.58 million Price / Sales0.91 Cash FlowN/A Price / CashN/A Book Value$0.90 per share Price / Book0.68 Profitability EPS (Most Recent Fiscal Year)($0.06) Net Income$-1,410,000.00 Net Margins-21.58% Return on Equity-4.11% Return on Assets-3.57% Miscellaneous Employees155 Outstanding Shares23,130,000Market Cap$14.11 Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions What is Pharma Bio Serv's stock symbol? Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV." How were Pharma Bio Serv's earnings last quarter? Pharma Bio Serv Inc (OTCMKTS:PBSV) announced its quarterly earnings data on Thursday, January, 29th. The company reported $0.04 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.03 by $0.01. The company earned $7.14 million during the quarter, compared to analyst estimates of $7.09 million. Pharma Bio Serv had a negative net margin of 21.58% and a negative return on equity of 4.11%. View Pharma Bio Serv's Earnings History. When is Pharma Bio Serv's next earnings date? Pharma Bio Serv is scheduled to release their next quarterly earnings announcement on Thursday, September, 13th 2018. View Earnings Estimates for Pharma Bio Serv. What is the consensus analysts' recommendation for Pharma Bio Serv? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pharma Bio Serv in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Pharma Bio Serv's key competitors? Some companies that are related to Pharma Bio Serv include Wilhelmina International (WHLM), Lightbridge (LTBR), TSS (TSSI), DIGIPATH Inc/SH SH (DIGP), Cartesian (CRTN), Transatlantic Capital (TACI), Green Energy Management Services (GRMS), HPIL Holding Common Stock (HPIL), CleanTech Innovations, Inc. Common Stock (SIXD) and China Xingbang Industry Group (CXGP). Who are Pharma Bio Serv's key executives? Pharma Bio Serv's management team includes the folowing people: Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 54)Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 47)Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 58) Has Pharma Bio Serv been receiving favorable news coverage? Media coverage about PBSV stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Pharma Bio Serv earned a coverage optimism score of 0.22 on Accern's scale. They also assigned headlines about the company an impact score of 46.22 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. How do I buy shares of Pharma Bio Serv? Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Pharma Bio Serv's stock price today? One share of PBSV stock can currently be purchased for approximately $0.61. How big of a company is Pharma Bio Serv? Pharma Bio Serv has a market capitalization of $14.11 million and generates $15.58 million in revenue each year. The company earns $-1,410,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma Bio Serv employs 155 workers across the globe. How can I contact Pharma Bio Serv? Pharma Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]corprominence.com. MarketBeat Community Rating for Pharma Bio Serv (OTCMKTS PBSV)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 44 (Vote Outperform)Underperform Votes: 47 (Vote Underperform)Total Votes: 91MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote "Outperform" if you believe PBSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/23/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?